Supplementary Material for manuscript entitled "Pharmacodynamic Modeling of Cinacalcet in Secondary Hyperparathyroidism: Efficacy and Influencing Factors Analysis"
* Precision expressed as coefficient of variation (CV). ** Expressed as % coefficient of variation. *** Expressed as nmol/min/mL. IC50: darapladib plasma concentration causing 50% inhibition of plasma
